BRANCH RETINAL VEIN OCCLUSION
Clinical trials for BRANCH RETINAL VEIN OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new BRANCH RETINAL VEIN OCCLUSION trials appear
Sign up with your email to follow new studies for BRANCH RETINAL VEIN OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye injection aims to tame leading causes of blindness
Disease control CompletedThis study tests the safety of an experimental eye injection called ONS-5010 (bevacizumab) in people with vision loss from wet age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion. Participants receive the injection and are monitored for side…
Matched conditions: BRANCH RETINAL VEIN OCCLUSION
Phase: PHASE3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New eye drug 601 shows promise in major trial for blurry vision
Disease control CompletedThis study tested a new medicine called 601 against an existing drug, ranibizumab, for people with vision loss due to a blocked vein in the eye (branch retinal vein occlusion). 351 adults received injections into the eye to reduce swelling and improve sight. The goal was to see i…
Matched conditions: BRANCH RETINAL VEIN OCCLUSION
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New eye scanner could replace dye injections for retinal disease
Diagnosis CompletedThis study tested a new imaging device called OCT angiography (OCTA) that takes 3D pictures of blood vessels in the back of the eye without needing dye injections. Researchers compared OCTA images to standard dye-based imaging in 88 people with retinal blood vessel problems or no…
Matched conditions: BRANCH RETINAL VEIN OCCLUSION
Sponsor: Heidelberg Engineering GmbH • Aim: Diagnosis
Last updated Jun 26, 2026 17:07 UTC